Delivery Order SPE2DX22D0020-SPE2D825F42WT

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order valued at $458,462.85 by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order falls within AmerisourceBergen's established role as a Pharmaceutical Prime Vendor, through which the company supplies comprehensive pharmaceutical products and medical supplies to support military and federal healthcare systems globally.

This award reflects AmerisourceBergen's critical position in the Defense Logistics Agency's medical procurement infrastructure, particularly as a primary supplier of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, the company's portfolio encompasses a wide range of medical commodities necessary to support military healthcare operations. The DLA Troop Support Medical contract vehicle provides flexibility for multiple delivery orders such as this one, enabling rapid procurement and distribution of essential pharmaceutical products to meet federal healthcare requirements.